Tag

CDMO (Contract Development & Manufacturing Operations)

1 article

Gland Pharma Q1 PAT Surges 47% YoY

Gland Pharma reported Q1 FY27 revenue of ₹18,003 Mn, a 20% YoY growth, driven by strong CDMO and B2B performance. Net profit surged 47% YoY to ₹3,170 Mn with PAT margin expanding by 330 bps to 18%, re